Modulating the activity of the proNGF-p75NTR-sortilin complex may hold the key to reducing neuronal apoptosis while promoting neuronal survival and functional recovery, thus presenting a new avenue for PD treatment. The gene discussed is NGFR; the disease is Parkinson disease.